Dhaka Medical College and Hospital is a public medical college and hospital located in Dhaka, the capital city of Bangladesh. It houses medical school as well as a tertiary care hospital on one campus. The country's first ever autologous bone marrow transplant took place in its bone marrow transplant unit.

During the past decade, Dhaka Medical College Hospital conducted 12 clinical trials. In the 10-year time frame, 12 clinical trials started and 3 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 2 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Dhaka Medical College Hospital" #1 sponsor was "Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh" with 2 trials, followed by "DR. MALA KHAN" with 2 trials sponsored, "Dhaka Medical College" with 2 trials sponsored, "Gynuity Health Projects" with 2 trials sponsored and "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)" with 2 trials sponsored. Other sponsors include 0 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Dhaka Medical College Hospital" #1 collaborator was "Dhaka Medical College" with 3 trials as a collaborator, "Bangladesh Reference Institute of Chemical Measurements (BRICM)" with 1 trials as a collaborator, "Breast Cancer Research Foundation" with 1 trials as a collaborator, "Hospital Israelita Albert Einstein" with 1 trials as a collaborator and "International Centre for Diarrhoeal Disease Research, Bangladesh" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Dhaka Medical College Hospital" are "Covid19" (4 trials), "Preeclampsia" (2 trials), "Acute Lymphoblastic Leukaemia" (1 trials), "Acute Respiratory Distress Syndrome" (1 trials) and "Acute Respiratory Failure" (1 trials). Many other conditions were trialed in "Dhaka Medical College Hospital" in a lesser frequency.

Most popular intervention types in "Dhaka Medical College Hospital" are "Drug" (7 trials), "Device" (4 trials), "Other" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "0.6% PVP-I Oral and nasal spray to asymptomatic to mild COVID-19 patient having multiple comorbidity" (1 trials), "0.6% PVP-I Oral and nasal spray to healthy volunteer" (1 trials), "0.6% PVP-I oral and nasal spray to moderately ill COVID-19 positive patient" (1 trials), "Adult bubble CPAP oxygen therapy device" (1 trials) and "Congo Red Dot Test" (1 trials). Other intervention names were less common.

The vast majority of trials in "Dhaka Medical College Hospital" are 11 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Dhaka Medical College Hospital". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 12 completed trials in Dhaka Medical College Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Dhaka Medical College Hospital, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".